Viewing Study NCT04563195


Ignite Creation Date: 2025-12-24 @ 2:14 PM
Ignite Modification Date: 2026-06-06 @ 5:13 PM
Study NCT ID: NCT04563195
Status: WITHDRAWN
Last Update Posted: 2022-01-27
First Post: 2020-09-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: BAFF/IL-17 Bispecific Antibody Treatment in Subjects With Primary Sjogren's Syndrome
Sponsor: Matthew C. Baker
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Sjogren's Syndrome View
Keywords: